![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 03, 2017 1:22:17 PM
http://www.plandaibiotech.com/president.html
We will, of course, continue our pharmaceutical testing. We have additional malaria trials set to commence next year using a combination green tea and artemisia drug, and we will be conducting a sports recover and sports injury trial using our citrus product. Once the cannabis product is profiled, our intent is to start testing for treating neural disorders including MS, Parkinson’s and epilepsy.
TXTM(S.Africa MMJ) is the one and ONLY MARIJUANA stock in South Africa!
Accumulate all you can!
$$$$$$$$$$ Go TXTM $$$$$$$$
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM